N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide

C55H59FN6O13 — CID 165053306

IUPACN-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)COCCC(=O)CNC(=O)[C@@H](CC(=O)CNC(=O)CCC(=O)CCCCCN1C(=O)C=CC1=O)Cc1ccccc1)CC3
InChIInChI=1S/C55H59FN6O13/c1-3-55(73)40-24-44-51-38(28-62(44)53(71)39(40)29-75-54(55)72)50-42(15-14-37-31(2)41(56)25-43(60-51)49(37)50)59-46(67)30-74-21-19-35(64)26-58-52(70)33(22-32-10-6-4-7-11-32)23-36(65)27-57-45(66)16-13-34(63)12-8-5-9-20-61-47(68)17-18-48(61)69/h4,6-7,10-11,17-18,24-25,33,42,73H,3,5,8-9,12-16,19-23,26-30H2,1-2H3,(H,57,66)(H,58,70)(H,59,67)/t33-,42+,55+/m1/s1
InChIKeyBRPGCXBYOQLDIO-HDCJUJGGSA-N
MW1031.10 g/mol
LogP3.49
Rot. Bonds25

About N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide

N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide (PubChem CID 165053306) has the molecular formula C55H59FN6O13 and a molecular weight of 1031.10 g/mol. Its IUPAC name is N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide.

Molecular Properties

Compound NameN-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide
PubChem CID165053306
Molecular FormulaC55H59FN6O13
Molecular Weight1031.10 g/mol
Exact Mass1030.41
IUPAC NameN-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)COCCC(=O)CNC(=O)[C@@H](CC(=O)CNC(=O)CCC(=O)CCCCCN1C(=O)C=CC1=O)Cc1ccccc1)CC3
InChIInChI=1S/C55H59FN6O13/c1-3-55(73)40-24-44-51-38(28-62(44)53(71)39(40)29-75-54(55)72)50-42(15-14-37-31(2)41(56)25-43(60-51)49(37)50)59-46(67)30-74-21-19-35(64)26-58-52(70)33(22-32-10-6-4-7-11-32)23-36(65)27-57-45(66)16-13-34(63)12-8-5-9-20-61-47(68)17-18-48(61)69/h4,6-7,10-11,17-18,24-25,33,42,73H,3,5,8-9,12-16,19-23,26-30H2,1-2H3,(H,57,66)(H,58,70)(H,59,67)/t33-,42+,55+/m1/s1
InChIKeyBRPGCXBYOQLDIO-HDCJUJGGSA-N
XLogP3.49
TPSA266.54 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds25
Heavy Atoms75
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001031.10
LogP ≤ 53.49
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
The IUPAC name of N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide (CID 165053306) is N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide.
What is the SMILES notation for N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
The canonical SMILES for N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide is CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)COCCC(=O)CNC(=O)[C@@H](CC(=O)CNC(=O)CCC(=O)CCCCCN1C(=O)C=CC1=O)Cc1ccccc1)CC3.
What is the InChIKey of N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
The InChIKey is BRPGCXBYOQLDIO-HDCJUJGGSA-N. The full InChI is InChI=1S/C55H59FN6O13/c1-3-55(73)40-24-44-51-38(28-62(44)53(71)39(40)29-75-54(55)72)50-42(15-14-37-31(2)41(56)25-43(60-51)49(37)50)59-46(67)30-74-21-19-35(64)26-58-52(70)33(22-32-10-6-4-7-11-32)23-36(65)27-57-45(66)16-13-34(63)12-8-5-9-20-61-47(68)17-18-48(61)69/h4,6-7,10-11,17-18,24-25,33,42,73H,3,5,8-9,12-16,19-23,26-30H2,1-2H3,(H,57,66)(H,58,70)(H,59,67)/t33-,42+,55+/m1/s1.
What are the key properties of N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide has a molecular weight of 1031.10 g/mol, XLogP of 3.49, 25 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4R)-4-benzyl-5-[[4-[2-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-2-oxoethoxy]-2-oxobutyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide is sourced from PubChem (CID 165053306), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).